Table 2 Posterior probability of haloperidol for delirium prevention for the primary and the secondary outcomes
Outcome | Measure | Estimate | Any Benefit | Any Harm | CIB | CIH |
|---|---|---|---|---|---|---|
Mortality | Risk difference |  − 0.01 (− 0.03, 0.02) | 70% | 30% | 12% | 4% |
Risk ratio | 0.97 (0.63, 1.39) | 56% | 44% | 29% | 22% | |
Delirium Incidence | Risk difference |  − 0.01 (− 0.09, 0.08) | 57% | 43% | 34% | 23% |
Risk ratio | 0.96 (0.69, 1.30) | 59% | 41% | 28% | 16% | |
Serious adverse event | Risk difference | 0.00 (− 0.01, 0.01) | 38% | 62% | 0% | 0% |
Risk ratio | 0.94 (0.35, 2.60) | 55% | 45% | 47% | 38% | |
Rescue BZD use | Risk difference |  − 0.01 (− 0.15, 0.12) | 56% | 44% | 41% | 30% |
Risk ratio | 0.97 (0.56, 1.58) | 56% | 44% | 33% | 25% | |
Extrapyramidal syndrome | Risk difference |  − 0.00 (− 0.04, 0.02) | 60% | 40% | 8% | 4% |
Risk ratio | 0.83 (0.37, 1.96) | 69% | 31% | 59% | 23% | |
QTc prolongation | Risk difference | 0.01 (− 0.02, 0.05) | 23% | 77% | 3% | 26% |
Risk ratio | 1.21 (0.70, 2.16) | 22% | 78% | 12% | 65% | |
Length of stay in ICU days | Mean difference |  − 0.20 (− 0.79, 0.31) | 80% | 20% | 1% | 0% |
Ration of means | 0.96 (0.88, 1.05) | 85% | 15% | 5% | 1% | |
Length of stay in hospital days | Mean difference |  − 0.03 (− 1.77, 1.94) | 54% | 46% | 10% | 4% |
Ration of means | 0.99 (0.86, 1.15) | 55% | 45% | 6% | 6% |